Ripple Foods secures $65 million in series C funding
Ripple Foods has announced a $65 million series C round led by Euclidean Capital, with participation from Goldman Sachs, Fall Line Capital, and existing investors including GV, Prelude Ventures, S2G Ventures, and Khosla Ventures.
Ripple Foods has announced a $65 million series C round led by Euclidean Capital, with participation from Goldman Sachs, Fall Line Capital, and existing investors including GV, Prelude Ventures, S2G Ventures, and Khosla Ventures. This round follows successful series A and B funding rounds and brings Ripple Foods’ total funding to date to $110 million.
Founded in 2014, Ripple’s intellectual property focuses on processes and ingredients that allow the company to more closely replicate animal-derived foods with plant-based ingredients. The company uses its Ripptein proprietary plant protein to make dairy-free foods that include a Greek yogurt alternative, a dairy-free milk, and dairy-free half and half.
“Ripple Foods is at the helm of shaping the future of food and reinventing how we use plant proteins to make dairy alternatives,” said Kathy Elsesser, global chair of the Consumer, Retail and Healthcare Groups in the Investment Banking Division of Goldman Sachs. “We are proud to invest in a company that has created one of the fastest growing plant-based product lines and is changing the way people think about how plant-based foods should taste and impact our health.”